William Blair Has Negative Forecast for ISRG Q2 Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) - Research analysts at William Blair lowered their Q2 2026 EPS estimates for shares of Intuitive Surgical in a report released on Wednesday, April 23rd. William Blair analyst B. Vazquez now anticipates that the medical equipment provider will post earnings of $1.88 per share for the quarter, down from their previous forecast of $1.91. The consensus estimate for Intuitive Surgical's current full-year earnings is $6.43 per share. William Blair also issued estimates for Intuitive Surgical's Q3 2026 earnings at $1.95 EPS and Q4 2026 earnings at $2.14 EPS.

ISRG has been the subject of a number of other research reports. Royal Bank of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday. Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Piper Sandler dropped their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Trading Up 1.3 %

ISRG stock traded up $6.46 during mid-day trading on Friday, reaching $514.59. 2,015,889 shares of the stock traded hands, compared to its average volume of 1,617,024. Intuitive Surgical has a 52-week low of $367.39 and a 52-week high of $616.00. The stock's fifty day moving average is $511.92 and its 200-day moving average is $533.05. The company has a market cap of $183.29 billion, a P/E ratio of 80.28, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company posted $1.50 EPS.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,454 shares of company stock valued at $18,564,027 in the last quarter. Insiders own 0.70% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth about $26,000. Global Financial Private Client LLC boosted its position in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Finally, BankPlus Trust Department bought a new stake in Intuitive Surgical in the fourth quarter valued at about $28,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.